Translated data: India's Ceremorphic company has launched a life sciences division, utilizing its AI chip technology platform BioCompDiscoverX to accelerate drug development. The company aims to identify better candidate molecules from the outset, bringing new drugs to market faster and more cost-effectively. Ceremorphic plans to fully roll out its technology platform by the end of 2024.